血糖波动与炎症因子在糖尿病下肢动脉病变发展中的作用:机制与临床意义
The Role of Blood Glucose Fluctuations and Inflammatory Factors in the Development of Diabetic Lower Extremity Arterial Disease: Mechanisms and Clinical Significance
DOI: 10.12677/acm.2025.15123602, PDF,   
作者: 魏 猛:承德医学院研究生学院,河北 承德;陈云霞*:沧州市人民医院内分泌代谢科,河北 沧州
关键词: 血糖波动炎症因子糖尿病下肢动脉病变Blood Glucose Fluctuations Inflammatory Factors Diabetes Mellitus Lower Extremity Arterial Disease
摘要: 糖尿病患者在生活中常常面临下肢动脉病变的显著风险,而血糖波动和炎症因子被认为在此病变的进展中扮演着关键角色。近年来,越来越多的研究表明,血糖波动不仅影响血糖控制,还可能通过诱导炎症反应,进一步促进下肢动脉的病理变化。本综述旨在系统分析血糖波动与炎症因子之间的相互作用,探讨其对糖尿病下肢动脉病变的影响机制。我们总结了最新的研究成果,揭示了血糖波动如何通过激活炎症途径来加剧下肢动脉病变的风险。同时,文章还讨论了在临床管理中需要关注的关键因素,以帮助降低糖尿病患者下肢动脉病变的发生率和进展。这些研究不仅为我们理解糖尿病并发症的病理机制提供了新的视角,也为临床治疗策略的优化提供了依据。
Abstract: Diabetic patients often face a significant risk of lower extremity arterial disease in daily life, and blood glucose fluctuations and inflammatory factors are believed to play key roles in the progression of this lesion. In recent years, a growing body of research has indicated that blood glucose fluctuations not only affect glycemic control but may also further promote pathological changes in the lower extremity arteries by inducing inflammatory responses. This review aims to systematically analyze the interaction between blood glucose fluctuations and inflammatory factors, and explore their underlying mechanisms in diabetic lower extremity arterial disease. We summarize the latest research findings, revealing how blood glucose fluctuations exacerbate the risk of lower extremity arterial disease by activating inflammatory pathways. Meanwhile, this article discusses the key factors that need attention in clinical management to help reduce the incidence and progression of lower extremity arterial disease in diabetic patients. These studies not only provide new insights into our understanding of the pathological mechanisms of diabetic complications but also offer a basis for the optimization of clinical treatment strategies.
文章引用:魏猛, 陈云霞. 血糖波动与炎症因子在糖尿病下肢动脉病变发展中的作用:机制与临床意义[J]. 临床医学进展, 2025, 15(12): 1850-1858. https://doi.org/10.12677/acm.2025.15123602

参考文献

[1] Sheybani, S., Kahrom, M., Ganjali, R., Kalati, S.M., Zirak, N. and Ghorani, V. (2023) Effects of Glargine on Hyperglycemia in Patients with Diabetes Mellitus Type II Undergoing Off-Pump Coronary Artery Bypass Graft: A Randomized, Controlled, Double-Blind Clinical Trial. Journal of Cardiovascular and Thoracic Research, 15, 44-50. [Google Scholar] [CrossRef] [PubMed]
[2] Yu, W., Zhou, D., Zhang, L., Rumeng, C., Zhang, P., Sun, L., et al. (2020) Effect of Sancai Powder on Glacemic Variability of Type 1 Diabetes in China: A Protocol for Systematic Review and Meta-Analysis. Medicine, 99, e20772. [Google Scholar] [CrossRef] [PubMed]
[3] Akbari, M. and Hassan-Zadeh, V. (2020) The Inflammatory Effect of Epigenetic Factors and Modifications in Type 2 Diabetes. Inflammopharmacology, 28, 345-362. [Google Scholar] [CrossRef] [PubMed]
[4] Zhao, J., Wang, A.H., Wang, B., Li, M.M., Li, L.Q. and Wei, X.W. (2024) Evaluation of Risk Factors in Diabetic Foot Infections with Systemic Inflammatory Response Syndrome. National Medical Journal of China, 104, 4303-4307.
[5] Jenkins, D.W., Thompson, K.M. and Goeddeke, N. (2024) How Canines Can Assist Our Patients with Diabetes: Diabetes Alert Dogs: What Are Their Capabilities? Journal of the American Podiatric Medical Association, 114, 22-125. [Google Scholar] [CrossRef] [PubMed]
[6] Dong, L., Ren, Y., Zhang, W., Liu, Y., Liu, M., Hong, C., et al. (2022) A Painless and Flexible Bi-Directional Blood Glucose-Regulating System Inspired by an Inverter Air Conditioner. Biomaterials Science, 10, 5318-5325. [Google Scholar] [CrossRef] [PubMed]
[7] Martinez, M., Santamarina, J., Pavesi, A., Musso, C. and Umpierrez, G.E. (2021) Glycemic Variability and Cardiovascular Disease in Patients with Type 2 Diabetes. BMJ Open Diabetes Research & Care, 9, e002032. [Google Scholar] [CrossRef] [PubMed]
[8] Ohara, H., Yamanaka, M., Inoue, K., Shimizu, H., Iguchi, N., Tanaka, K., et al. (2025) Case Report: Role of Hypoglycemia in Seizure Aggravation in a Case of Focal Epilepsy: Revealing a Missing Link between Diabetes and Dementia. Frontiers in Neuroscience, 19, Article 1604552. [Google Scholar] [CrossRef] [PubMed]
[9] Fatulla, P., Imberg, H., Sterner Isaksson, S., Hirsch, I.B., Mårtensson, J., Liljebäck, H., et al. (2025) Evaluating the Adequacy of Coefficient of Variation and Standard Deviation as Metrics of Glucose Variability in Type 1 Diabetes Based on Data from the GOLD and SILVER Trials. Diabetes Technology & Therapeutics, 27, 606-612. [Google Scholar] [CrossRef] [PubMed]
[10] Lu, Q., Wang, Z., Bai, S., Wang, Y., Liao, C., Sun, Y., et al. (2023) Hydrophobicity Regulation of Energy Acceptors Confined in Mesoporous Silica Enabled Reversible Activation of Optogenetics for Closed-Loop Glycemic Control. Journal of the American Chemical Society, 145, 5941-5951. [Google Scholar] [CrossRef] [PubMed]
[11] Canseco, J.A., Chang, M., Karamian, B.A., Nicholson, K., Patel, P.D., Shenoy, K., et al. (2022) Postoperative Glycemic Variability as a Predictor of Adverse Outcomes Following Lumbar Fusion. Spine, 47, E304-E311. [Google Scholar] [CrossRef] [PubMed]
[12] Niu, W.C., Liu, C., Liu, K., Fang, W.J., Liu, X.Q., Liang, X.L., et al. (2024) The Effect of Different Times of Day for Exercise on Blood Glucose Fluctuations. Primary Care Diabetes, 18, 427-434. [Google Scholar] [CrossRef] [PubMed]
[13] Chen, F., Wang, P., Dai, F., Zhang, Q., Ying, R., Ai, L., et al. (2025) Correlation between Blood Glucose Fluctuations and Osteoporosis in Type 2 Diabetes Mellitus. International Journal of Endocrinology, 2025, Article 8889420. [Google Scholar] [CrossRef] [PubMed]
[14] Mizoguchi, T., Aoyama, N., Jinnouchi, Y., Inoue, M., Eguchi, E. and Ohira, T. (2025) Associations of Fluctuations in Blood Glucose and Insulin with Hypoglycemic Symptoms. Scientific Reports, 15, Article No. 11579. [Google Scholar] [CrossRef] [PubMed]
[15] Al-Rashed, F., Sindhu, S., Arefanian, H., Al Madhoun, A., Kochumon, S., Thomas, R., et al. (2020) Repetitive Intermittent Hyperglycemia Drives the M1 Polarization and Inflammatory Responses in THP-1 Macrophages through the Mechanism Involving the TLR4-IRF5 Pathway. Cells, 9, Article 1892. [Google Scholar] [CrossRef] [PubMed]
[16] Fang, T.Z., Wu, X.Q., Zhao, T.Q., et al. (2024) Influence of Blood Glucose Fluctuations on Chemotherapy Efficacy and Safety in Type 2 Diabetes Mellitus Patients Complicated with Lung Carcinoma. World Journal of Diabetes, 15, 645-653. [Google Scholar] [CrossRef] [PubMed]
[17] Cai, Y., Zhang, H., Li, Q. and Zhang, P. (2022) Correlation between Blood Glucose Variability and Early Therapeutic Effects after Intravenous Thrombolysis with Alteplase and Levels of Serum Inflammatory Factors in Patients with Acute Ischemic Stroke. Frontiers in Neurology, 13, Article 806013. [Google Scholar] [CrossRef] [PubMed]
[18] Zhang, X., Wang, H., Xie, C., Hu, Z., Zhang, Y., Peng, S., et al. (2022) Shenqi Compound Ameliorates Type-2 Diabetes Mellitus by Modulating the Gut Microbiota and Metabolites. Journal of Chromatography B, 1194, Article 123189. [Google Scholar] [CrossRef] [PubMed]
[19] Reda, R.M., El-Murr, A., Abdel-Basset, N.A., Metwally, M.M.M. and Ibrahim, R.E. (2024) Infection Dynamics of Shewanella Spp. in Nile Tilapia under Varied Water Temperatures: A Hematological, Biochemical, Antioxidant-Immune Analysis, and Histopathological Alterations. Fish & Shellfish Immunology, 149, Article 109588. [Google Scholar] [CrossRef] [PubMed]
[20] Zhu, Q., Kang, J., Xu, G., Li, J., Zhou, H. and Liu, Y. (2020) Traditional Chinese Medicine Shenqi Compound to Improve Lower Extremity Atherosclerosis of Patients with Type 2 Diabetes by Affecting Blood Glucose Fluctuation. Medicine, 99, e19501. [Google Scholar] [CrossRef] [PubMed]
[21] Tapia, J., Vera, N., Aguilar, J., González, M., Sánchez, S.A., Coelho, P., et al. (2021) Correlated Flickering of Erythrocytes Membrane Observed with Dual Time Resolved Membrane Fluctuation Spectroscopy under Different D-Glucose Concentrations. Scientific Reports, 11, Article No. 2429. [Google Scholar] [CrossRef] [PubMed]
[22] Zhang, C., Tang, M., Lu, X., Zhou, Y., Zhao, W., Liu, Y., et al. (2020) Relationship of Ankle-Brachial Index, Vibration Perception Threshold, and Current Perception Threshold to Glycemic Variability in Type 2 Diabetes. Medicine, 99, e19374. [Google Scholar] [CrossRef] [PubMed]
[23] Wang, L., Yang, H., Zhang, C., Zhang, Y., He, Y., Liu, Y., et al. (2024) A Blood Glucose Fluctuation-Responsive Delivery System Promotes Bone Regeneration and the Repair Function of Smpd3-Reprogrammed BMSC-Derived Exosomes. International Journal of Oral Science, 16, Article No. 65. [Google Scholar] [CrossRef] [PubMed]
[24] Battelino, T., Danne, T., Bergenstal, R.M., Amiel, S.A., Beck, R., Biester, T., et al. (2019) Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations from the International Consensus on Time in Range. Diabetes Care, 42, 1593-1603. [Google Scholar] [CrossRef] [PubMed]
[25] Marso, S.P., Daniels, G.H., Brown-Frandsen, K., Kristensen, P., Mann, J.F.E., Nauck, M.A., et al. (2016) Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. New England Journal of Medicine, 375, 311-322. [Google Scholar] [CrossRef] [PubMed]
[26] Zinman, B., Wanner, C., Lachin, J.M., Fitchett, D., Bluhmki, E., Hantel, S., et al. (2015) Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. New England Journal of Medicine, 373, 2117-2128. [Google Scholar] [CrossRef] [PubMed]
[27] McMurray, J.J.V., Solomon, S.D., Inzucchi, S.E., Køber, L., Kosiborod, M.N., Martinez, F.A., et al. (2019) Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. New England Journal of Medicine, 381, 1995-2008. [Google Scholar] [CrossRef] [PubMed]
[28] Green, J.B., Bethel, M.A., Armstrong, P.W., Buse, J.B., Engel, S.S., Garg, J., et al. (2015) Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. New England Journal of Medicine, 373, 232-242. [Google Scholar] [CrossRef] [PubMed]
[29] ORIGIN Trial Investigators (2012) Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia. New England Journal of Medicine, 367, 319-328. [Google Scholar] [CrossRef] [PubMed]
[30] Cameron, A.R., et al. (2016) Anti-Inflammatory Effects of Metformin via AMPK. Proceedings of the National Academy of Sciences of the United States of America, 113, E3100-E3101.
[31] UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of Intensive Blood-Glucose Control with Metformin on Complications in Overweight Patients with Type 2 Diabetes (UKPDS 34). The Lancet, 352, 854-865.